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Summary
Objective: To determine the relationship between synovial fluid, chondroitin sulfate disaccharide and hyaluronic acid to differing degrees of
experimental temporomandibular joint (TMJ) osteoarthritis (OA).
Design: Twenty-four merino sheep were divided into three groups and had different TMJ surgical procedures to produce OA. Group I; control
(six sheep), Group II; disc perforation (nine sheep) and Group III; disc perforation and articular damage (nine sheep). Synovial fluid was
collected initially and at sacrifice at 3 months. Chondroitin 4-sulfate, chondroitin 6-sulfate and hyaluronic acid were measured and correlated
to the OA histologic score.
Results: The chondroitin-sulfate levels were significantly increased (Group I to Group II P<0.001; Group I to Group III P<0.001), the
hyaluronic acid levels decreased (Group I to Group II P<0.01; Group I to Group III P<0.01) with the increasing OA score.
Conclusion: Chondroitin-sulfate and hyaluronic acid show a correlation with surgically created TMJ osteoarthritis in sheep model. © 2001
OsteoArthritis Research Society International
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Temporomandibular joint disorders (TMD) cover a range of
muscular and articular disorders1,2. In the last decade,
there has been considerable interest in characterizing the
different types of intraarticular TMJ pathologies. Plain
radiographs do not correlate well with intraarticular pathol-
ogy, but represent past remodeling of the condyle3. Arthro-
grams and magnetic resonance imaging demonstrate disc,
condyle and fossa relationships and marked pathology
such as disc perforation and osteoarthritis (OA). However,
these findings can also be commonly demonstrated in
asymptomatic joints, which limits the diagnostic value of
those imaging techniques. Arthroscopy allows direct imag-
ing, primarily of the superior joint space, which has allowed
the evaluation of the disc and the articular surface by the
presence of adhesions and inflammation4. More recently
interest has been directed at the molecular level5. In the
early stage, cartilage microfibrillation or degradation is
not shown by any arthroscopic examination. These initial365degradative events will result in alteration of the biochemi-
cal composition of the synovial fluid (SF)6–8. Thus, interest
has focused on the early diagnosis and related markers in
SF for TMD7.
Chondroitin-sulfate (CS) isomers are useful markers in
SF of knee and hip OA9–16, rheumatoid arthritis (RA)15 and
traumatic arthritis15,16. Yoshihara et al.13 have shown the
increased levels of chondroitin 4-sulfate (C4S) and chon-
droitin 6-sulfate (C6S) in knee OA and following rupture of
the anterior cruciate ligament. Generally it is accepted that
CS levels increase and hyaluronic acid (HA) levels
decrease in OA and acute trauma11,17,18. Whether or not
this applies to the TMJ is unconfirmed. Although the TMJ
has many similarities to the knee and hip, articular cartilage
is different, with the knee and hip being hyaline cartilage
and the TMJ fibrocartilage. There are also technical prob-
lems associated with the small size of the TMJ and hence
the difficulty in obtaining adequate samples for accurate
quantitation. Several reports show increased chondroitin-
sulfate levels in TMJ SF for patients with TMD19–21.
The Japan–Australia Temporomanibular Joint Disorder
(TMD) Research Group has produced a number of stand-
ardized models for systematic study of intraarticular TMJ
pathology2,23–24. These include a model of advanced
OA22, which involved articular damage to induce OA and
has been used to study the effects of different types of
surgical reconstruction25–27. It was also found that the OA
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the joint space shortly after OA induction28. The early
stages of OA without advanced progression can be induced
by disc perforation24.
The aim of this paper is to investigate the changes in CS
and HA levels in control, early and late OA in the sheep
TMJ.HISTOLOGICAL PREPARATION OF THE TMJ
The fixed blocks were decalcified with 9.5% hydrochloric
acid and 1% sodium acetate over saturated EDTA. Each
specimen was sectioned in a parasagittal plane into lateral,
central and medial specimens. These specimens were
sectioned at 5 m thickness and stained with hematoxylin
and eosin. Each specimen was assessed at its anterior,
central and posterior aspects, thus dividing the joint into
nine zones. Each zone was evaluated, both descriptively
and by adding the index of osteoarthritic score according to
the modified method by Ishimaru and Goss (Table I)22. A
double determination was performed 1 week from the first
observation. The OA score was then determined for each
joint by the mean of the scores from the nine zones.
BIOCHEMICAL ANALYSIS OF THE SYNOVIAL FLUID
The synovial fluid specimen was diluted 10-fold with
distilled water and digested with chondroitinase ABC(0.625 U/ml) and hyaluronidase SD (33 mU/ml) derived
from streptococcus dysgalactiae (HAase SD, Seikagaku
corporation, Japan). To 200 l of diluted joint fluid, 50 l of
chondroitinase ABC solution in distilled water was added
80 l of 10 mM of sodium acetate buffer (pH 8.0), and 70 l
of distilled water. The mixture was incubated at 37°C for 2 h
and then ultrafiltered. The filtrate obtained was analysed by
high performance liquid chromatography (HPLC).Table I
Osteoarthritic score
The temporal bone
No change 0
Progressive remodeling 1
Fibrillation 2
Fibrous adhesion 3
Complete loss of trabecular pattern 4
Bony destruction 5
The disc
No change 0
Disc thinning 1
Disc tearing or torn 2
Disc perforation 3
Fibrous adhesion 4
Complete loss of the disc 5
The condyle (surface morphology)
No change 0
Fibrillation 1
Denudation, eburnation 2
Osteophyte, flattening, sclerosis 3
Fibrous repair 4
Fibrous ankylosis 5
The condyle (bone structure)
No change 0
Bone remodeling 1
Downgrowth of articular soft tissue 2
Sub-cortical cyst formation 3
Marrow fibrosis 4
Complete loss of trabecular pattern 5HPLC ANALYSIS
HPLC analysis of the unsaturated disaccharides derived
from chondroitin-sulfate in the joint fluid was performed
according to the method of Toyoda et al.29 and Shinmei
et al.15. Briefly, the HPLC analysis system consists of two
pumps (model 880-PU, Japan Spectroscopic Co. Ltd.,
Tokyo, Japan), an autosampling injector, a stainless
steel column packed with silica gel (YMC gel PA-120), a
spectrofluorometer (model 820-FP, Japan Spectoroscopic),
and an integrator (model 805-GI, Japan Spectroscopic).
The unsaturated disaccharides in each sample were
eluted with a gradient of 0–100 sodium sulfate for 60 min
at a flow rate of 0.5 ml/min. To the eluant from the column
was added 100 mM sodium tetraborate buffer containing
10 mg/ml of cyanoacetamide. Then the mixture was
passed through a polyetheletherketone (PEEK) reaction
coil set in the dry reaction bath at 137°C. The effluent
was monitored by spectrofluorometer set at an excitation
of 331 nm and emission of 383 nm. Each peak correspond-
ing to unsaturated dissacharide was calculated by the
integrator.Materials and methods
Twenty-four adult Merino sheep, each weighing approxi-
mately 60 kg, were used in this study and their manage-
ment followed our previously described technique22,23. Six
sheep (Group I) were unoperated and acted as controls.
Nine sheep (Group II) had a surgically created disc perfo-
ration24. Nine sheep (Group III) had surgically induced
OA22.
In Groups II and III, anesthesia was induced with an
injection of thiopentone sodium into the external jugular
vein. Intubation was performed and anesthesia was main-
tained with isoflurane/N2O/O2. The right unilateral pre-
auricular region was shaved and prepared with antiseptic
solution and draped with a sterilized sheet. A vertical skin
incision was made to the pre-auricular region and under-
lying tissue was dissected to expose the lateral capsule of
the TMJ. Both the superior and the inferior joint space were
opened by horizontal incisions to expose the condylar
surface. In the central part of the disc a 3.8 mm diameter of
perforation was then surgically created, using a round
punch. In Group III, additional surgery was performed
by gentle removal of both the articular fibrous cover and
the underlying superficial fibrocartilage with a scalpel
and periosteal elevator according to the method used by
Ishimaru and Goss22. Then the wound was rinsed with
normal saline and closed in layers. The sheep were
returned to field conditions after 1 week’s observation in a
covered animal house.
At 3 months all sheep were reanesthetized and SF was
collected by aspiration through the capsule; they were then
killed by anesthetic overdose into the external jugular vein.
The TMJ was removed ‘en bloc’ with a band saw and fixed
in neutral buffered formalin. In Group I, SF was collected
from the superior joint space in the TMJ under intravenous
sedation with thiopentone. SF was placed in individual
containers, and immediately centrifuged at 3000 rpm for
5 min to get rid of cell debris, then deeply frozen and stored
at −70°C before analysis.
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Colorimetric determination of the disaccharide derived
from HA was performed by Morgan–Elson’s method.
Briefly, the unsaturated disaccharide in each sample was
reacted with Ehrlich reagent. After the reaction, absorbance
was measured at 585 nm. The concentration of HA
of sample was calculated from the analytical value of
standard HA solution.STATISTICAL ANALYSIS
Data were stored and analysed with Statview 4.5 by a
Macintosh computer. ANOVA and Fisher’s PLSD were
applied for the analysis of CS and HA levels in SF of the
three groups. Kruskal–Wallis test and Mann–Whitney
U-analysis were applied for the comparison of OA scores
among the groups. Regression analysis was performed
and correlations were analysed by Spearman’s rank corre-
lation coefficient between OA score and CS, HA levels in
SF. P-values less than 0.05 were considered significant.ResultsHISTOLOGICAL FINDINGS
For Group I, control TMJs (Fig. 1), osteoarthritic score
was 0. Generally, Group II showed adaptive remodeling
and early OA (Fig. 2). There was a consistency in histo-
logical changes in Group II. Group III showed typical OA
(Fig. 3) and there was a consistency in histological
changes. Generally the osteoarthritic stage was low in
Group II and higher in Group III (Fig. 4). There was a
significant difference of OA scores between Group I and II
(*P<0.0001), Group I and Group III (*P<0.0001), and
Group II and Group III (**P<0.0001, Fig. 4).Fig. 1. Histological appearance of normal sheep TMJ of Group I.
(T: temporal bone, D: disc, C: condyle, HE×2.)Fig. 2. Histological appearance of sheep TMJ of disc perforation in
Group II. (T: temporal bone, D: disc, C: condyle, HE×2.)Fig. 3. Histological appearance of osteoarthritic sheep TMJ of
Group III. (T: temporal bone, D: disc, C: condyle, HE×2.2.)Fig. 4. Comparison of OA stages (mean and S.D.) among Group I,
II and III. Statistical analysis shows that OA scores are significantly
high in Group II and III (*P<0.0001) compared to Group I, and
significantly high in Group III (**P<0.0001) compared to Group II.
(P<0.0001, Kruskal–Wallis test, and Mann–Whitney U-analysis as
post-hoc.)
SYNOVIAL FLUID ANALYSES
The measured CS isomers levels and HA concentrations
are presented in Table II. Generally, GAG isomers such as
chondroitin 4-sulfate (Di4S) and chondroitin 6-sulfate
(Di6S) increased in Group II and, more markedly, in
Group III. There were statistically significant differences
both between Group I and Group III (P<0.001), and Group
II and Group III (P<0.001). Di6S/Di4 increased accord-ing the group number with significant differences among
any groups (P<0.01, P<0.001). On the other hand, HA
concentration decreased in Groups II and III (P<0.01)
compared with Group I.
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PARAMETERS IN SF
A significant positive correlation was observed between
OA scores and C6S (r=0.866, P<0.0001, Fig. 5), C4S
(r=0.870, P<0.0001, Fig. 6), C4S+C6S(r=0.068,
P<0.0001, Fig. 7) and C6S/C4S(r=0.828, P<0.0001,
Fig. 8). However, a significant negative correlation was
observed between OA scores and HA(r= −0.692, P<0.01,
Fig. 9).Table II
Released chondroitin-sulfate isomers and hyaluronic acid concentrations in sheep TMJ synovial fluid by
experimental group
Di6S Di4S Di6S+Di4S Di6S/Di4S HA
Group I 5.9±0.4 4.9±0.3 10.8±0.5 1.2±0.3 2.8±0.2
(Control) (3.7–8.2) (3.9–6.5) (8.5–14.5) (0.8–1.9) (1.8–4.6)
Group II 11.5±1.4 6.8±0.6 18.4±2.0 1.7±0.2 2.5±0.2
(Early OA) (5.4–16.3) (4.1–8.4) (9.5–24.5) (1.1–2.2) (1.5–3.3)
Group III 49.3±7.8 23.6±2.7 72.9±10.5 2.0±0.4 1.9±0.2
(Advanced OA) (25.2–93.8) (13.0–38.5) (40.8–132.3) (1.2–2.5) (0.9–3.6)
GI vs GII n.s. n.s. n.s. P<0.01 n.s.
GI vs GIII P<0.001 P<0.001 P<0.001 P<0.001 P<0.01
GII vs GIII P<0.001 P<0.001 P<0.001 P<0.001 P<0.01
Di6S, Di4S (g/ml), HA (mg/ml) mean±S.D., with ranges.
ANOVA and Fisher’s PLSD; n.s.: not significant.Fig. 5. Correlation between level of chondroitin 6-sulfate in TMJ
synovial fluid and OA stage. A significant positive correlation was
observed (Spearman’s rank correlation coefficient, r=0.866,
P<0.0001).Fig. 6. Correlation between level of chondroitin 4-sulfate in TMJ
synovial fluid and OA stage. A significant positive correlation was
observed (Spearman’s rank correlation coefficient, r=0.870,
P<0.0001).Discussion
In this study a strong correlation was demonstrated
between the severity of osteoarthritic changes and the
released CS and HA levels in SF of the sheep TMJ.
Histologically, Group II with the surgical disc perforation
and minor osteoarthritic changes was consistent with early
OA. Group III showed typical OA. C6S, C4S, the sum of
C6S and C4S and the ratio of C6S to C4S showed a strong
positive correlation to osteoarthritic changes and those
parameters increased well in accordance with the intra-
articular osteoarthritic changes. In contrast, HA showed a
strong negative correlation to the OA changes. Theseresults strongly suggest that intraarticular pathology is
reflected in SF, and those markers have a diagnostic
potential in SF analysis. Clinically, SF is the only material
readily obtainable from human TMJ, meaning that this
biochemical analysis may be useful for real time diagnosis
for clinical patients.
This study is consistent with the findings of orthopedic
research, which have shown that CS level increases and
HA level decreases in SF of joints with OA. However, such
clinical and experimental studies were done in knee and hip
joints. There have been limited studies to evaluate CS and
HA levels in human TMJ19–21. Those studies were done
using SF lavage, and this remains a problem for a precise
calibration of each parameter. Thus, an experimental study
was indispensable in order to confirm the correlationship
between CS and HA levels in TMJ SF and histological
changes.
Previous studies reported that C6S is the main CS of
articular cartilage30. Thus, the C6S level in SF has been
considered to represent the degree of matrix degradation.
This coincides with the results of this study. However,
recent studies suggest that biosynthesis of CS may
increase in the early stage of OA in order to attempt repair,
but if this attempt fails then subsequent OA may result11,18.
Therefore it is still controversial whether the increased level
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tion or the result of hypersynthesis to an attempt at repair17.
On the other hand, HA is mainly secreted by synovio-
cytes in synovial membrane. In this study HA concentration
decreased in SF in accordance with the OA progress. This
finding coincides with previous reports31,32. In this patho-
logical condition, however, it is still controversial whether
biosynthesis of HA from synovial membrane decreased or
body fluid infiltration reduces HA concentration. Recently, a
clinical cross-sectional study showed decreased levels of
HA and GAG in OA compared with normal11. Further
studies are necessary to examine the calibrated CS and
HA levels by total GAG or total protein and to evaluate the
correlationship between those levels in TMJ SF and his-
tology. Thus, at present, clinical data from TMJ SF must be
considered with caution. However, in OA intraarticular fric-
tion may occur, causing cartilage damage. Intraarticular
matrix degradation then gradually develops, and a vicious
circle is formed. This is an essential difference of human
OA from experimentally induced OA. Thus, there is alimitation to the simulation of human OA in experimental
models. However, it is important to find the several evi-
dences of articular pathology for the research of human
OA.
Certainly further investigation is necessary to define the
precise correlationship between the levels of several syno-
vial markers and ongoing intraarticular pathology in the
TMJ. However, from this study it can be concluded that
C4S, C6S and HA are strongly correlated with intraarticular
pathology in the TMJ.Fig. 7. Correlation between sum level of chondroitin 6-sulfate and
chondroitin 4-sulfate in TMJ synovial fluid and OA stage. A
significant positive correlation was observed (Spearman’s rank
correlation coefficient, r=0.868, P<0.0001).Fig. 8. Correlation between ratio of C6S to C4S in TMJ synovial
fluid and OA stage. A significant positive correlation was observed
(Spearman’s rank correlation coefficient, r=0.828, P<0.0001).Fig. 9. Correlation between HA level of in TMJ synovial fluid and
OA stage. A significant negative correlation was observed (Spear-
man’s rank correlation coefficient, r= −0.692, P<0.01).References
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